<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04311164</url>
  </required_header>
  <id_info>
    <org_study_id>Steno Tech Survey</org_study_id>
    <nct_id>NCT04311164</nct_id>
  </id_info>
  <brief_title>The Steno Tech Survey: A Study of Insulin Pump Users With Type 1 Diabetes</brief_title>
  <official_title>The Steno Tech Survey: A Multisite Exploratory Study of People With Type 1 Diabetes on Insulin Pump Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Steno Diabetes Center Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nordsjaellands Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Steno Diabetes Center Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This survey study seeks to contribute with new knowledge about the variation in clinical and
      psychosocial outcomes of people with Type 1 diabetes on insulin pump therapy. Potential
      sources of variation that are investigated in this study include both individual
      characteristics, such as demographics and socioeconomic status, and behavioral factors, such
      as psychological and preference structures. The study is conducted at two hospital sites in
      Denmark.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">April 30, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Glycated Hemoglobin A1c (HbA1c)</measure>
    <time_frame>1 year: From April 2020 (first survey distribution) to April 2021 (second survey distribution)</time_frame>
    <description>Information on HbA1c in mmol/mol will be extracted from patients' medical records</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Psychological well-being</measure>
    <time_frame>1 year: From April 2020 (first survey distribution) to April 2021 (second survey distribution)</time_frame>
    <description>Measured with a questionnaire in the surveys</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes distress</measure>
    <time_frame>1 year: From April 2020 (first survey distribution) to April 2021 (second survey distribution)</time_frame>
    <description>Measured with a questionnaire in the surveys</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported diabetes and insulin pump-specific behavior</measure>
    <time_frame>1 year: From April 2020 (first survey distribution) to April 2021 (second survey distribution)</time_frame>
    <description>Measured with questionnaires in the surveys</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Educational preferences</measure>
    <time_frame>1 year: From April 2020 (first survey distribution) to April 2021 (second survey distribution)</time_frame>
    <description>Measured with questionnaires at T1 and discrete choice experiment at T2</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1400</enrollment>
  <condition>Diabetes Mellitus, Type 1</condition>
  <arm_group>
    <arm_group_label>Steno Tech Survey Respondents</arm_group_label>
    <description>This cohort is expected to consist of 1,400 people with Type 1 diabetes on insulin pump therapy treated at either Steno Diabetes Center Copenhagen or Nordsjællands Hospital Hilleroed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention given.</intervention_name>
    <description>Two survey questionnaires (T1 and T2). Each questionnaire is composed of multiple items including pre-coded (multiple choice) questions, dichotomous (yes/no) questions, rating scales and validated questionnaire scales to measure general and diabetes/insulin pump-specific behavior, psychosocial/psychological concepts and preferences.</description>
    <arm_group_label>Steno Tech Survey Respondents</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consists of adults (18+) with Type 1 diabetes on insulin pump therapy
        treated at either Steno Diabetes Center Copenhagen or Nordsjaellands Hospital
        (approximately 1,400 people).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria (for surveyed group):

          -  Adult (18+ years)

          -  Type 1 diabetes

          -  Insulin pump user

          -  Danish-speaking

        Exclusion criteria (for surveyed group):

          -  Child ([0;18[ years)

          -  No access to Danish digital mail (e-Boks)

          -  Non-Danish speaking
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Signe Schmidt, MD-PhD</last_name>
    <phone>+4551174785</phone>
    <email>signeschmidt@regionh.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kristoffer P. Madsen, MSc</last_name>
    <phone>+4521351737</phone>
    <email>kristoffer.panduro.madsen@regionh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Steno Diabetes Center Copenhagen</name>
      <address>
        <city>Gentofte</city>
        <zip>2820</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Signe Schmidt, MD-PhD</last_name>
      <phone>+4551174785</phone>
      <email>signe.schmidt@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Kristoffer P. Madsen, MSc</last_name>
      <phone>+4521351737</phone>
      <email>kristoffer.panduro.madsen@regionh.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Kirsten Nørgaard, MD-PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karen Rytter</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ingrid W. Tapager</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Henrik U. Andersen, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eva Hommel, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Timothy C. Skinner, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bryan R. Cleal, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mette A. Nexø, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nordsjællands Hospital Hillerød</name>
      <address>
        <city>Hillerød</city>
        <zip>3400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrik Pedersen-Bjergaard, MD-PhD</last_name>
      <phone>+4520823632</phone>
      <email>Ulrik.Pedersen-Bjergaard@regionh.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 11, 2020</study_first_submitted>
  <study_first_submitted_qc>March 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2020</study_first_posted>
  <last_update_submitted>March 14, 2020</last_update_submitted>
  <last_update_submitted_qc>March 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Steno Diabetes Center Copenhagen</investigator_affiliation>
    <investigator_full_name>Signe Schmidt</investigator_full_name>
    <investigator_title>MD, PhD, Researcher</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

